SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage…
Expands Capital Base and Increases Total Available Liquidity to ~$760 Million DUBLIN and STAMFORD, Conn. and NEW YORK, June 25,…
Expands Lender Relationships to Further Support Platform's Growth DUBLIN and STAMFORD, Conn. and NEW YORK, June 10, 2025 /PRNewswire/ --…